See also this year's filing and all EDGAR filings for this company.
PDF Report 0000109657_2024_GT_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000109657, GT Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,056,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 53,000 |
| 4 | LiabilitiesCurrent | 6,633,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,115,063 |
| 9 | ResearchAndDevelopmentExpense | 6,973,663 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,529,242 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,109,000 |
| 1 | Liabilities | 6,633,000 |
| 2 | Expenses | 14,088,726 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,476,000 |
| 5 | NetIncome | -8,559,484 |
| 6 | ComprehensiveNetIncome | -8,559,484 |
| 7 | BaseVar | 20,179,984 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.746 |
| 9 | EconomicCapitalRatio | 2.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
